This approach has already proven its value, providing valuable new insight into how the compound DAPT interacts with the multiple-substrate regulated forms of γ-secretase and the implications this has for amyloid precursor protein processing in Alzheimer’s disease (Walsh, 2014). This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.